BRIEF-Valeant Pharmaceuticals provides update on regulatory matters
May 31 (Reuters) - Valeant Pharmaceuticals International Inc :
* On issuance of MCTOS,alternative information guidelines,confirms co has fulfilled intentions on compliance with alternative info guidelines
* Autorité des marchés financiers issued a customary management cease trade order on May 17, 2016 relating to trading in securities of co by co's CEO and CFO
* Valeant Pharmaceuticals to hold conference call on June 7, 2016
* There have been no material changes to information relating to company's delay in making Canadian required filings Source text for Eikon: Further company coverage:
© Thomson Reuters 2016 All rights reserved.